The global fibrotic diseases treatment market is at a pivotal point, propelled by significant advancements in understanding the cellular mechanisms of tissue scarring and a pressing unmet clinical need. Fibrotic diseases, which involve excessive accumulation of extracellular matrix (scar tissue) in vital organs like the lungs, liver, and kidneys, contribute substantially to global mor... https://www.databridgemarketresearch.com/reports/global-fibrotic-diseases-treatment-market